Home Options CRMReports

CRM

Salesforce, Inc.Close $180.10EOD only

Max Pain

$177.50

Next expiry May 22, 2026

Expected Move

±$6.28

3.5% from close

Price Gap

-2.60

Distance to max pain

IV Rank

Middle-high premium

P/C OI

0.74

Slightly call-heavy

Consensus

4/4

Partial coverage

Published snapshot: May 20, 2026 close

End-of-day snapshot

This page reflects CRM options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot

May 20, 2026 close

CRM Directional Report

Analysis based on market close March 31, 2026

Directional Theta Gang Flow Earnings Consensus

Consensus-supported lens with chain history and key metrics in the rail.

Outlook

Neutral-to-bearish with a gravitational pull toward $190-$195 max pain levels. Confidence: 7.5/10. The regime is dominated by negative GEX (trending) and mixed flow, suggesting volatility and potential downside pressure, but the proximity to max pain provides a short-term magnet.

Confidence:

7.5 / 10

Base 5; +2 GEX/flow strongly aligned (negative GEX, net bearish premium); +0.5 spot 1.8% from MP. No overrides.

Supports: Negative GEX (-$13.5M) favors trending moves, net premium flow bearish (-$35.3M), spot below near-term max pain.
Conflicts: Mixed flow regime (P/C vol 1.07, P/C OI 0.86) and rising max pain trend ($190→$195) suggest underlying bullish gravity.

📉Negative GEX (-$13.5M) indicates dealer hedging amplifies spot moves.

🧲Spot below $190 max pain creates a short-term pinning magnet.

Regime Classification

Vol Regime

Normal

IV 46% is elevated (Normal regime) — selling premium has edge on rich vol, but negative GEX adds risk.

Gamma Regime

Trending

GEX -$13.5M (Trending) — dealers are net short gamma, hedging flows will amplify spot moves, not suppress them.

Flow Regime

Mixed

Flow: Mixed — net premium bearish (-$35.3M) but P/C ratios are near parity, showing no clear directional consensus.

Spot vs Max Pain

Below

Spot vs MP: Below — current price ($186.67) is 1.8% below the $190 near-term max pain, creating upward gravitational pull.

Thesis duration: Multi-week — Negative GEX is structural, not tied to a single expiry. Max pain ladder shows a persistent $190-$195 zone across multiple weeks, and the flow regime (mixed) is consistent. This supports a multi-week range/trend thesis.

Price Range Forecast

Next 2 days

$182.74$190.60

Max pain pin at $190 for 4/2 expiry dominates; break below $182.74 EM low invalidates.

Next 1 week

$177.67$195.67

Negative GEX can fuel moves to either EM bound; max pain at $190-$195 provides upside bias.

Next 2 weeks

$174.57$198.77

Rising max pain trend to $195 and structural call OI walls above $200 cap explosive upside.

Key Levels

Max pain pins: $190 (2026-03-27); $185 (2026-04-02); $190 (2026-04-10)

EM guardrails: 2d $182.74/$190.60; 1w $177.67/$195.67

Support:

Resistance: $210.00 · $220.00 · $230.00

Structural: **Call OI walls at $200, $210, $220, $230** act as major upside caps. Distant $550 calls are likely legacy positions. **Put OI floor is weak** (only $190 notable), leaving downside more open.

Dealer Positioning (GEX/DEX)

GEX: $-13.5M

DEX: +20.5M shares

Gamma flip: N/A

NTM gamma: No specific gamma flip level provided. With **negative GEX**, dealer hedging will **add to momentum** in the direction of spot moves (buy on rallies, sell on dips). A move ±2% from here accelerates dealer activity, increasing volatility.

IV Analysis

IV vs VIX: IV 46% is rich — favorable for premium sellers, but the negative GEX regime increases the risk of large moves.

Term structure: **Steeply upward sloping** from 33.9% (2d) to 48.4% (38d), then settles ~43%. **Key kink at 5/8 expiry (48.4%)**, likely pricing an event (possibly earnings anticipation).

Skew: **5/8 expiry (38 DTE) IV is 48.4% vs. 5/15 (45 DTE) at 40.6% — a ~8 vol-point differential.** This supports a reverse calendar spread (sell rich 5/8, buy cheaper 5/15).

Flow Analysis

Net premium: **Net premium -$35.3M bearish**; P/C vol 1.07 (balanced), P/C OI 0.86 (slight call bias in positioning).

Directional prints: **1) $180P 5/15: Vol 34,261 vs OI 3,570 (9.6x).** Could be bought puts for protection or sold puts for income; bearish premium flow at $180 supports bought interpretation. **2) $190C 5/15: Vol 25,946 vs OI 776 (33.4x).** Likely bought calls given high volume/OI ratio and bullish premium flow at $190. **Structural flow summary:** Massive bearish premium at deep OTM strikes ($180, $250, $260, $330) suggests institutional put buying for tail-risk hedging.

Unusual: $172.50C 4/17 with IV 50.1% — far OTM call with elevated vol, could be a speculative long or part of a complex spread.

Risks & Catalysts

!**Negative GEX (-$13.5M):** Dealer hedging amplifies spot moves, increasing the risk of sharp, trending breaks from the range.

!**Elevated IV (46%):** Risk of vol crush, especially on any range-bound consolidation, hurting long premium positions.

!**Weak Put Support:** Lack of concentrated put OI below $190 leaves the downside technically open for a swift move toward the weekly EM low ($177.67).

!**Earnings Catalyst (5/27 est.):** Vol term structure is already elevated into May, implying event risk is being priced in.

Strategy Viability

Strategy	Edge	Best Setup	Primary Risk
Long Stock	Moderate-Weak	N/A	Negative GEX and bearish net premium flow provide headwinds; better to wait for a test of the $182.74 support.
Short Stock	Moderate	N/A	Negative GEX supports trending downside, but max pain pin and rising MP trend create strong counter-trend gravity near $190.
Covered Call	Moderate-Strong	Own stock, sell the $195C 4/17 (above max pain, near weekly EM high).	Stock rallies past $195, shares called away; negative GEX could fuel a faster move up.
Cash-Secured Put / Put Spread	Moderate-Strong	Sell $180/$175 put spread 5/15 (below support, collects rich 45 DTE vol).	Break below $175 EM support; negative GEX accelerates losses.
Long Calls	Moderate-Weak	Buy $190C 4/10 (targeting max pain pin).	IV is rich (37%), and negative GEX can cause whipsaw; pin may not materialize.
Long Puts / Bear Put Spread	Moderate	Buy $185P / Sell $180P 4/17 bear put spread (betting on failure to hold max pain).	Max pain pin to $190 causes time decay; IV crush on range-bound action.
Iron Condor	Weak	$182.5P/$177.5P x $195C/$200C 4/17 (within EM bounds).	Negative GEX regime strongly disfavors range-bound strategies; high risk of a break outside wings.
Calendar/Diagonal	Moderate-Strong	Reverse Calendar: Sell $190C 5/8 (48.4% IV), Buy $190C 5/15 (40.6% IV). Benefits from vol differential decay.	Directional move away from $190 hurts; pin at $190 maximizes theta/vol harvest.
PMCC / LEAPS Diagonal	Moderate	Buy $190C Jan 2027 (43.3% IV), Sell $195C 4/17 or 5/8 against it.	Capital intensive; near-term pin failure and negative GEX can pressure short leg.

Top Plays

Reverse Calendar Spread (Vol Harvest)

Sell $190C 5/8, Buy $190C 5/15. Estimated debit: ~$1.20.

**Exploits the 8 vol-point kink in term structure.** The short leg is in the richer 5/8 expiry (48.4% IV), the long leg in cheaper 5/15 (40.6%). Benefits from vol contraction and theta decay on the short leg, especially if spot pins near $190.

Debit: $1.10-$1.30

Max loss: $1.30

BE: Complex; profit from IV differential collapse and pinning.

Mgmt: Manage at 50% max profit; exit if spot moves >$5 away from $190 or if the IV differential narrows to <3 points.

Traders comfortable with negative gamma environments who want a non-directional, volatility-based play.

Bullish Put Spread (Premium Collection)

Sell $180/$175 Put Spread, Exp 5/15. Estimated credit: ~$1.25.

**Collects rich 45 DTE vol while defining risk below key support.** Aligns with the multi-week thesis of a drift toward max pain ($190-$195) and uses the $175 strike (below the 2-week EM low) as a defined risk buffer. The 45 DTE provides time for the pin to work.

Credit: $1.15-$1.35

Max loss: $3.75

BE: $178.75

Mgmt: Take profit at 60-70% of max credit; exit if spot closes below $180.

Traders with a neutral-to-bullish bias seeking defined-risk income; better for smaller accounts than CSPs.

Covered Call Overlay

If long stock, sell the $195C 4/17. Estimated credit: ~$2.00.

**Generates income against existing stock in a pinning regime.** The $195 strike is above near-term max pain and just below the weekly EM high, offering a high probability of expiring worthless. The 17 DTE is ideal for the multi-week pinning thesis.

Credit: $1.80-$2.20

Max loss: Unlimited above $195 (share called away)

BE: $188.67

Mgmt: Roll up and out if spot approaches $195; close at 80% profit if possible.

Existing shareholders looking to enhance yield in a range-bound, high-IV environment.

Watchlist Triggers

Entry Triggers

IFIf spot rallies to tag $190 (max pain) and stalls for 1 hour. → Enter Reverse Calendar: Sell $190C 5/8, Buy $190C 5/15.

IFIf spot declines to $182.74 (2d EM low) and finds support. → Sell the $180/$175 put spread 5/15.

Exit Triggers

EXITIf spot closes below $177.67 (1w EM low). → Exit all bullish/non-directional positions (put spreads, calendars).

EXITIf the IV differential between 5/8 and 5/15 $190C narrows to <3 vol points. → Exit the reverse calendar spread for a profit.

Tactical Summary

Primary thesis: Multi-week pinning struggle between negative GEX (trending) and max pain gravity ($190-$195). Favors defined-risk premium collection on tests of support or volatility arbitrage around the pin. Invalidation is a close below $177.67. Top plays: 1) Reverse calendar for vol traders, 2) Bullish put spread for income seekers, 3) Covered call for shareholders.

How to Use These Reports

This directional reflects the market close on March 31, 2026.

What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.